Lucira Health Investor Relations Material
Latest events
Q3 2022
Lucira Health
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Lucira Health Inc
Access all reports
Lucira Health Inc developed molecular diagnostic testing kits for infectious diseases, including at-home and point-of-care tests. The company focused on integrating lab-quality results with user-friendly digital health solutions. Its products were designed for rapid detection and convenience. The company was headquartered in Emeryville, California, and its shares were listed on the NASDAQ.
Latest articles
)
Verisure: Security Leader Ready for a Comeback IPO
Verisure, Europe's leading monitored alarm provider, is preparing a comeback IPO in 2025 that could be one of the year's most significant listings.
16 Sep 2025
)
Stephen J. Squeri: American Express Veteran Chairman and CEO
Stephen Squeri has spent over four decades at American Express, rising through the ranks to lead one of the world's most recognized brands.
15 Sep 2025
)
Where to? The Story of Uber
Uber's journey from rule-breaking disruptor to disciplined dual-app giant, now shaping the future of mobility, delivery, and autonomy.
5 Sep 2025
Ticker symbol
LHDX
Country
🇺🇸 United States